ArticleFrontiers in endocrinology2022

Radioactive Iodine for the Treatment of Subclinical Thyrotoxicosis Grade 1 and 2: Outcome of up to 18-Year Follow Up.

Jason Phowira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.